Friday, February 3, 2023
Home News Pharma News

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

More than 400 people will benefit from CAR-T therapy NICE approval 

Over 400 people with an aggressive form of lymphoma are set to benefit from the first CAR-T therapy recommended for routine use in the...
Scientists explain emotional ‘blunting’ caused by SSRIs

Scientists explain emotional ‘blunting’ caused by SSRIs

The University of Cambridge scientists have discovered why selective serotonin reuptake inhibitors (SSRIs) cause emotional ‘blunting’. In a new study, scientists have found out why...
Chemotherapy before surgery reduces the risk of colon cancer returning 

Chemotherapy before surgery reduces the risk of colon cancer returning 

Cancer Research UK finds that giving colon cancer patients chemotherapy before surgery cuts their risk of the disease returning. In a new Cancer Research UK-funded...
Oxford University leading research on programmable nucleic acid drugs

Oxford University leading research on programmable nucleic acid drugs

A consortium led by the University of Oxford researchers has been awarded £8m of funding to unlock the potential of programmable nucleic acid drugs.  Programmable...
Reimagining drug delivery and diagnostics

Reimagining drug delivery and diagnostics

BioNxt Solutions’ Hugh Rogers explains how the company is driving forward innovation in drug delivery methods and diagnostics technology. Canadian-headquartered life sciences company, BioNxt Solutions,...
Children on medication for depression has risen by almost 60% in the UK

Children on medication for depression has risen by almost 60% in the UK 

Prescription of medication for depression in children is up by nearly 60%, according to a new study from the University of Aberdeen.   The same study...
Less than four in 100 men eligible to be sperm donors  

Less than four in 100 men eligible to be sperm donors  

International research of over 11,700 men in Denmark and the US finds that less than four in 100 men are accepted as sperm donors.  A...
Vitamin D supplements can reduce the risk of melanoma 

Vitamin D supplements can reduce the risk of melanoma 

Fewer cases of melanoma were found in regular users of vitamin D supplements than in non-users, according to a new study.  People who regularly take...
A new cure for dystonia is under development

A new cure for dystonia is under development

A research team in Korea have made significant steps towards finding a cure for dystonia, offering hope to thousands of musicians.   Musicians’ dystonia affects 1-3%...
Perseverant bacteria are weakening antibiotic treatment

Perseverant bacteria are weakening antibiotic treatment

Bacterial perseverance is a new phenomenon that could help explain how bacteria are able to adapt to survive antibiotic treatment.  A team of researchers from...
UCL team gain access to the most powerful supercomputer for drug discovery 

UCL team gain access to the most powerful supercomputer for drug discovery 

A UCL-led team of researchers are using the world’s first exascale supercomputer to identify a shortlist of potential new drugs for diseases.   The supercomputer called...
Can ketamine help treat severe alcohol disorder?

Can ketamine help treat severe alcohol disorder?

A new trial from the University of Exeter will investigate whether ketamine-assisted therapy could help treat alcohol disorder. The £2.4 million trial will be delivered...
NICE has recommended the anti-cancer drug Enhertu for earlier use

NICE has recommended the anti-cancer drug Enhertu for earlier use

Hundreds more people are now eligible for the breast cancer drug Enhertu as NICE recommends for use in the disease’s early stages This means NICE...

Over 5,200 people could benefit from new chronic lung disease recommendations  

The National Institute of Health and Care Excellence (NICE) has recommended that nintedanib to treat chronic lung disease can be extended to more people....

Over 40,000 doses of Oxford’s Ebola vaccine heading to Uganda 

University of Oxford’s Ebola vaccine has been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.   Oxford’s Ebola vaccine...
New mRNA cancer vaccine significantly reduces disease  

New mRNA cancer vaccine significantly reduces disease  

An mRNA cancer vaccine, developed by Moderna and Merck, demonstrated a statistically significant and clinically meaningful reduction in risk of disease recurrence or death.  The...
WHO warns that bacterial infections are becoming harder to treat

WHO warns that bacterial infections are becoming harder to treat

The World Health Organization (WHO) has reported that resistance to antibiotics is on the rise, making the treatment of bacterial infections more difficult. According to...
Should patients choose their own type 2 diabetes medication?

Should patients choose their own type 2 diabetes medication?  

A new study has suggested that patients should be put in charge of their own type 2 diabetes medication.   The Trimaster large-scale study is the...
Treating cognitive decline after cholestatic liver disease

Treating cognitive decline after cholestatic liver disease

Patients with cholestatic liver disease may develop neurological symptoms including fatigue and cognitive decline, for which there is currently no cure.  Cholestatic liver diseases such...
Re-examining the safety of fluoroquinolones

Re-examining the safety of fluoroquinolones

A review into the use of fluoroquinolones has found discrepancies in the safety data issued by regulatory bodies. Fluoroquinolones are commonly prescribed family of antibiotics....

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest